Analystreport

Proteostasis Therapeutics Inc (NASDAQ: PTI) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating.

PROTEOSTASIS THERAPEUTICS  (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview